Genetic Epidemiology of HCV-related Liver Disease

HCV 相关肝病的遗传流行病学

基本信息

  • 批准号:
    7918135
  • 负责人:
  • 金额:
    $ 15.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-15 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): An estimated 20-30% of the four million Americans with hepatitis C infection (HCV) are projected to develop advanced fibrosis and cirrhosis after 2-3 decades of infection. Differences in exposure to fibrosis-promoting risk factors like alcohol abuse likely explain some of this difference in fibrosis risk. However, current research suggests that genetic factors may also influence the risk of advanced fibrosis in HCV patients. Two factors that research has repeatedly shown to be associated with development of advanced liver disease are male gender and abdominal obesity. However, the specific role genetic factors, including those related to male sex hormone receptor or androgen receptors (AR) and to insulin resistance (IR) associated with abdominal obesity, may play in fibrosis risk remains unclear. The goal of the proposed study is to ascertain the role that changes in AR and IR genes play in increasing risk of advanced fibrosis. The associated specific aims are: 1) to identify and collect data on a large and representative cohort of male veterans with HCV infection; 2) to test the hypothesis that 'high risk" variants of genes related to IR either alone or in conjunction with abdominal obesity increase fibrosis risk; and 3) to test the hypothesis that 'high risk' variants of genes related to AR also increase fibrosis risk. Aim 1 will be accomplished with standard epidemiology methods for cohort identification and will be performed at the Michael E. DeBakey VA. Aims 2 and 3 will be addressed through a case-control study in which cohort members with advanced fibrosis (cases) are compared to those with mild fibrosis (controls). The research plan, didactic training and outstanding mentoring environment will work together to allow the principal investigator to acquire new skills as well as refine existing skills in the development and execution of novel genetic epidemiology studies, allowing her to develop into an independent investigator in genetic epidemiology of chronic liver and digestive disorders.
描述(由申请人提供): 据估计,400万丙型肝炎感染(HCV)的美国人中有20-30%预计在感染2-3年后发展为晚期纤维化和肝硬化。暴露于纤维化促进风险因素(如酗酒)的差异可能解释了纤维化风险的一些差异。然而,目前的研究表明,遗传因素也可能影响HCV患者晚期纤维化的风险。研究一再表明与晚期肝病发展相关的两个因素是男性性别和腹部肥胖。然而,具体的作用遗传因素,包括那些与男性性激素受体或雄激素受体(AR)和胰岛素抵抗(IR)与腹部肥胖,可能在纤维化的风险仍然不清楚。这项研究的目的是确定AR和IR基因的变化在增加晚期纤维化风险中的作用。相关的具体目的是:1)识别和收集大量有代表性的HCV感染男性退伍军人队列的数据; 2)检验与IR相关的基因的“高风险”变体单独或与腹部肥胖相关的基因的“高风险”变体增加纤维化风险的假设;和3)检验与AR相关的基因的“高风险”变体也增加纤维化风险的假设。目标1将采用标准流行病学方法进行队列识别,并将在Michael E. DeBakey VA.目的2和3将通过一项病例对照研究来解决,在该研究中,将患有晚期纤维化的队列成员(病例)与患有轻度纤维化的队列成员(对照)进行比较。研究计划,教学培训和优秀的指导环境将共同努力,使主要研究者获得新的技能,并完善现有的技能,在开发和执行新的遗传流行病学研究,使她能够发展成为一个独立的研究者在遗传流行病学的慢性肝脏和消化系统疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donna Lorraine White其他文献

Donna Lorraine White的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donna Lorraine White', 18)}}的其他基金

Sex hormones and HCV-related liver disease progression
性激素和 HCV 相关肝病进展
  • 批准号:
    9979785
  • 财政年份:
    2017
  • 资助金额:
    $ 15.79万
  • 项目类别:
Androgen Receptor Pathway and Risk of Hepatic Fibrosis in Hepatitis C
丙型肝炎中雄激素受体途径和肝纤维化风险
  • 批准号:
    8446061
  • 财政年份:
    2013
  • 资助金额:
    $ 15.79万
  • 项目类别:
Androgen Receptor Pathway and Risk of Hepatic Fibrosis in Hepatitis C
丙型肝炎中雄激素受体途径和肝纤维化风险
  • 批准号:
    8653960
  • 财政年份:
    2013
  • 资助金额:
    $ 15.79万
  • 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
  • 批准号:
    7928376
  • 财政年份:
    2008
  • 资助金额:
    $ 15.79万
  • 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
  • 批准号:
    8128652
  • 财政年份:
    2008
  • 资助金额:
    $ 15.79万
  • 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
  • 批准号:
    7514173
  • 财政年份:
    2008
  • 资助金额:
    $ 15.79万
  • 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
  • 批准号:
    7686059
  • 财政年份:
    2008
  • 资助金额:
    $ 15.79万
  • 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
  • 批准号:
    8319548
  • 财政年份:
    2008
  • 资助金额:
    $ 15.79万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.79万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了